Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 3
2009 1
2010 1
2011 6
2012 6
2013 4
2014 6
2015 2
2016 1
2017 3
2018 4
2019 1
2020 2
2021 6
2022 10
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial.
Wei J, Lu X, Liu Q, Fu Y, Liu S, Zhao Y, Zhou J, Chen H, Wang M, Li L, Yang J, Liu F, Zheng L, Yin H, Yang Y, Zhou C, Zeng P, Zhou X, Ding N, Chen S, Zhao X, Yan J, Fan X, Guan W, Liu B. Wei J, et al. Among authors: yin h. Nat Commun. 2023 Aug 14;14(1):4904. doi: 10.1038/s41467-023-40480-x. Nat Commun. 2023. PMID: 37580320 Free PMC article. Clinical Trial.
Willingness to Pay for Green Office: Evidence from Shanghai.
Zhang Y, Yin H. Zhang Y, et al. Among authors: yin h. Environ Sci Pollut Res Int. 2022 Dec;29(56):84345-84356. doi: 10.1007/s11356-022-21555-6. Epub 2022 Jul 2. Environ Sci Pollut Res Int. 2022. PMID: 35779220
Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real-world retrospective observational study (CTONG2004-ADV).
Xu CR, Chen Q, Zhou C, Wu L, Li W, Zhang H, Li Y, Xu F, Xiong J, Wang Q, Zhang H, Jiang Y, Yin H, Wu Q, Dai Q, Hu J, Chen J, Zhang J, Wu G, Yin J, Zhao J, Liu B, Shan J, Sheng L, Chen Q, Han Z, Shi H, Liu Y, Chen J, Wu YL. Xu CR, et al. Among authors: yin h. Transl Lung Cancer Res. 2023 Jan 31;12(1):127-140. doi: 10.21037/tlcr-22-852. Epub 2023 Jan 16. Transl Lung Cancer Res. 2023. PMID: 36762057 Free PMC article.
64 results